Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $796.4450 (0.54%) ($796.4450 - $802.8000) on Thu. Nov. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.16% (three month average) | RSI | 63 | Latest Price | $796.4450(0.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(54%) XBI(46%) SDY(44%) SPLV(41%) | Factors Impacting REGN price | REGN will decline at least -0.58% in a week (0% probabilities). VXX(-40%) USO(-18%) VIXM(-16%) UNG(-16%) TBT(-16%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.58% (StdDev 1.16%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $800.89 | 5 Day Moving Average | $795.1(0.17%) | 10 Day Moving Average | $806.97(-1.3%) | 20 Day Moving Average | $800.89(-0.56%) | To recent high | -5.8% | To recent low | 2.8% | Market Cap | $84.446b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |